XFOR
X4 Pharmaceuticals, Inc. · Healthcare
COO Mary Dibiase sold $38K of X4 Pharmaceuticals, Inc.
Sold$38,329
$0.57Price
67,695Shares
−13%Stake
What XFOR did after the filing
- The stock from Tue, Oct 8 close, $16.23
- −32.0%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the Nov 19 close.
Traded Mon, Oct 7. Filed Tue, Oct 8, 12:44 PM ET, during the session. Returns use the Oct 8 close and the Nov 19 close. Not investment advice.